Short-Form engagement platform

Building our own platform, should mean tight control over the features, functions and content. The finished platform should be exactly what we want!

By doing this, we will protect our brand and retain our customers’ trust as well as life time value.

We would need to bring together brand new digital, operations, and business transformation teams. We aren’t really set up to deliver digital solutions.

Can we keep up with constant technology evolution? How long before our solution is out of date? What is the cost of maintenance and keeping up with evolving consumer technology adoption?

We would need to spend months on the acquisition of strategic partnerships and procurement.

We need to budget for two years of investment, before we see any return or revenue.

We might get it wrong or we could well just miss the market opportunity.

How long would it take to build the right team, expertease and chemistry. We don’t have behavioural scientists, data scientists, designers or game developers? And who would they report into?

At latest at the end of this we will own the technology and platform IP.

With a white labelled solution we can protect our brand and retain our customers trust and relationship.

We can quickly engage with our target audience through pre configured social and digital channels, without the painful process of onboarding, technical and legal integration.

An API framework for wearable technology makes it much easier to ingest important biomarkers like Blood Glucose, Activity, Heart Rate and Sleep.

The available content management tools means that we can quickly add and classify all of our existing branded content.

We are confident that future consumer tech evolution and operating system updates are captured in the Nudg roadmap, reducing the need for a costly support and maintenance team.

We are confident that so far the Nudg team are always adding the latest API’s (for wearable technology and social channels) to their platform architecture.

The rules engine is so easy to configure, and we trust that the work done by the world class behaviour and data science team at nudg is robust.

We accelerated from discovery to live in market well under six months.

We like the simple licence model.

Corporate integration and security is critical. AWS is a powerful foundation and gives us confidence that we can scale into new geographies and countries efficiently and inexpensively.

We are aware of a number of platform partners available in the market who have been able to build a healthy online audience.

Do they understand our challenges? The majority of these partners are based in the United States. They could have a limited understanding of the EU and UK clinical, ethical, geographical or cultural challenges?

We like the positive interaction with their strong teams. They have applied their aggregated expertise to mobile health successfully.

Should we be worried about the dilution of our brand? If we recommend a solution to our customers does that mean that we lose the relationship?

What if our partner received bad press or any high profile liable action. How does this effect us?

When we did our technical diligence, the partner platform wasn’t as flexible as we would like. We would need to build other services around it for true 360 audience engagement and effectiveness.

We are concerned that the platform was built for a general audience making it difficult to tailor for more specific clinical and behavioural programs like Chronic condition management.

We have a real problem with our patient data sharing. Who does it belong too now? Who owns our customer?

What will stop our customers from leaving and using the partner directly? Its a real concern that a big part of our proposition will be threatened.